Novartis AG v Dexcel Pharma Limited [2008] EWHC 1266 (Pat)

In June 2008, Daniel Alexander QC and Mark Chacksfield acted for Novartis in obtaining an interim injunction in a patent dispute concerning one of Novartis’ leading products, NEORAL®, a cyclosporin formulation. The case involved the question of the extent to which the court was bound by an earlier court’s approach to interpretation of the claims and Mr Justice Floyd handed down judgment in June 2008.